These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34537422)

  • 1. Severity of Acute Graft-versus-Host Disease and Associated Healthcare Resource Utilization, Cost, and Outcomes.
    Farhadfar N; Leather HL; Wang S; Burton N; IrizarryGatell V; Itzler R; Salloum RG; Wingard JR
    Transplant Cell Ther; 2021 Dec; 27(12):1007.e1-1007.e8. PubMed ID: 34537422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Outcomes and Healthcare Resource Utilization for Gastrointestinal Acute Graft-versus-Host Disease after Allogeneic Transplantation for Hematologic Malignancy: A Retrospective US Administrative Claims Database Analysis.
    Johnson BH; Taylor A; Kim G; Drahos J; Yang J; Akbari M; Shah NN
    Biol Blood Marrow Transplant; 2019 Apr; 25(4):834-841. PubMed ID: 30625389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality, length of stay and costs associated with acute graft-versus-host disease during hospitalization for allogeneic hematopoietic stem cell transplantation.
    Yu J; Parasuraman S; Shah A; Weisdorf D
    Curr Med Res Opin; 2019 Jun; 35(6):983-988. PubMed ID: 30461314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inpatient Healthcare Resource Utilization, Costs, and Mortality in Adult Patients with Acute Graft-versus-Host Disease, Including Steroid-Refractory or High-Risk Disease, following Allogeneic Hematopoietic Cell Transplantation.
    Yu J; Judy JT; Parasuraman S; Sinha M; Weisdorf D
    Biol Blood Marrow Transplant; 2020 Mar; 26(3):600-605. PubMed ID: 31678539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic and Clinical Burden of Virus-Associated Hemorrhagic Cystitis in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation in the United States.
    McGuirk J; Divine C; Moon SH; Chandak A; Zhang Z; Papanicolaou GA
    Transplant Cell Ther; 2021 Jun; 27(6):505.e1-505.e9. PubMed ID: 33775616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Healthcare resource utilization and costs associated with acute graft-versus-host disease following allogeneic hematopoietic cell transplantation.
    Yu J; Lal L; Anderson A; DuCharme M; Parasuraman S; Weisdorf D
    Support Care Cancer; 2020 Nov; 28(11):5491-5499. PubMed ID: 32172407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and Outcomes of Bacterial Bloodstream Infections during Acute Graft-versus-Host Disease Involving the Gastrointestinal Tract after Hematopoietic Cell Transplantation.
    Petersen J; Lindner C; Hakki M
    Biol Blood Marrow Transplant; 2019 Aug; 25(8):1648-1653. PubMed ID: 31002988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic burden of acute steroid-refractory graft-versus-host disease in commercially insured pediatric patients.
    Grabner M; Strati E; Sandman K; Forsythe A
    J Manag Care Spec Pharm; 2021 May; 27(5):607-614. PubMed ID: 33908282
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical and Economic Burden of Multiple Double-Stranded DNA Viral Infections after Allogeneic Hematopoietic Cell Transplantation.
    Hill JA; Moon SH; Chandak A; Zhang Z; Boeckh M; Maziarz RT
    Transplant Cell Ther; 2022 Sep; 28(9):619.e1-619.e8. PubMed ID: 35764288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Preemptive Therapy for Cytomegalovirus on Hospitalizations and Cost after Hematopoietic Stem Cell Transplantation.
    Fang J; Su Y; Zavras PD; Raval AD; Tang Y; Perales MA; Giralt S; Stern A; Papanicolaou GA
    Biol Blood Marrow Transplant; 2020 Oct; 26(10):1937-1947. PubMed ID: 32640313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healthcare Resource Utilization and Costs of Steroid-Associated Complications in Patients With Graft-Versus-Host Disease.
    Bell EJ; Yu J; Bhatt V; Bunner SH; Lal LS; Galvin J; Weisdorf D
    Transplant Cell Ther; 2022 Oct; 28(10):707.e1-707.e7. PubMed ID: 35483620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Health Care Utilization and Costs during Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia and Myelodysplastic Syndromes in Adolescents and Young Adults Compared with Children: A Multicenter Study.
    Rangarajan HG; Smith LC; Stanek JR; Hall M; Abu-Arja R; Auletta JJ; O'Brien SH
    Biol Blood Marrow Transplant; 2019 May; 25(5):1031-1038. PubMed ID: 30625391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healthcare utilization and financial impact of acute-graft-versus host disease among children undergoing allogeneic hematopoietic cell transplantation.
    Ricci A; Jin Z; Broglie L; Bhatia M; George D; Garvin JH; Hall M; Satwani P
    Bone Marrow Transplant; 2020 Feb; 55(2):384-392. PubMed ID: 31537901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet and Red Blood Cell Transfusions and Risk of Acute Graft-versus-Host Disease after Myeloablative Allogeneic Hematopoietic Cell Transplantation.
    Gjærde LK; Sørensen ALT; von Stemann JH; Fischer-Nielsen A; Hansen MB; Sengeløv H; Ostrowski SR
    Transplant Cell Ther; 2021 Oct; 27(10):866.e1-866.e9. PubMed ID: 34252580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between histopathological alterations and diarrhea severity in acute intestinal graft-versus-host disease.
    da Costa LNG; Costa-Lima C; de Meirelles LR; Carvalho RB; Colella MP; Aranha FJP; Vigorito AC; De Paula EV
    Medicine (Baltimore); 2018 May; 97(19):e0600. PubMed ID: 29742694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective database analysis of healthcare resource utilization and costs in patients who develop post-transplant lymphoproliferative disease within the first year following allogeneic hematopoietic stem cell transplants.
    Watson C; Xu H; Princic N; Sruti I; Barlev A
    J Med Econ; 2020 Oct; 23(10):1159-1167. PubMed ID: 32643493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late Effects of Severe Acute Graft-versus-Host Disease on Quality of Life, Medical Comorbidities, and Survival.
    Rashid N; Krakow EF; Yeh AC; Oshima MU; Onstad L; Connelly-Smith L; Vo P; Mielcarek M; Lee SJ
    Transplant Cell Ther; 2022 Dec; 28(12):844.e1-844.e8. PubMed ID: 36057421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased serum albumin as a biomarker for severe acute graft-versus-host disease after reduced-intensity allogeneic hematopoietic cell transplantation.
    Rezvani AR; Storer BE; Storb RF; Mielcarek M; Maloney DG; Sandmaier BM; Martin PJ; McDonald GB
    Biol Blood Marrow Transplant; 2011 Nov; 17(11):1594-601. PubMed ID: 21806949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and economic burden associated with graft-versus-host disease following allogeneic hematopoietic cell transplantation in France.
    Michonneau D; Quignot N; Jiang H; Reichenbach D; Kelly M; Burrell A; Zhang X; Thiruvillakkat K; Mohty M
    Bone Marrow Transplant; 2023 May; 58(5):514-525. PubMed ID: 36765178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomegalovirus in Allogeneic Hematopoietic Transplantation: Impact on Costs and Clinical Outcomes Using a Preemptive Strategy.
    Saullo JL; Li Y; Messina JA; Thompson J; Dalton T; Giri VK; Reed SD; Miller R; Horwitz ME; Alexander BD; Sung AD
    Biol Blood Marrow Transplant; 2020 Mar; 26(3):568-580. PubMed ID: 31712193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.